Hanna Wacker

Hanna Wacker focuses her practice on capital markets transactions as well as general securities-related matters.

Ms. Wacker’s experience at Skadden includes advising, among others:

Capital Markets (Equity)

• Euronext Brussels and Euronext Amsterdam-listed ONWARD Medical, a leading developer of spinal cord injury therapies, in connection with a cash capital increase
• Jefferies and BofA Securities as joint global coordinators and joint bookrunners in connection with capital increases of Zur Rose Group AG

Capital Markets (Equity-Linked/Debt)

• ONWARD Medical in connection with a loan agreement

Mergers and Acquisitions

• the management and supervisory boards of Fresenius in the company’s exit from the Austrian and international businesses of VAMED AG
• Armira and Boxine in Boxine’s €1 billion business combination with 468 SPAC I SE, one of the first de-SPAC transactions in the market involving a German-listed blanc cheque company
• SIGNA Sports United GmbH in connection with its US$3.3 billion initial public offering on the New York Stock Exchange as a result of its de-SPAC merger with Yucaipa Acquisition Corporation. The merger also included the acquisition of WiggleCRC Group

Prior to joining Skadden’s Frankfurt office, Ms. Wacker worked as a research assistant and completed a legal clerkship in New York.